ATE536880T1 - Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie - Google Patents

Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie

Info

Publication number: ATE536880T1
Authority: AT; Austria
Prior art keywords: allergy; rape; peptides; treatment; ragweed
Prior art date: 2008-08-15

Application number

AT09251252T

Other languages

English (en)

Inventor

Mark Larche

Roderick Peter Hafner

Paul Laidler

Original Assignee

Circassia Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-15

Filing date

2009-05-01

Publication date

2011-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41090318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE536880(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-08-15 Priority claimed from GB0814986A external-priority patent/GB0814986D0/en

2008-08-20 Priority claimed from GB0815218A external-priority patent/GB0815218D0/en

2009-05-01 Application filed by Circassia Ltd filed Critical Circassia Ltd

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE536880T1 publication Critical patent/ATE536880T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
206010020751 Hypersensitivity Diseases 0.000 title abstract 2
208000026935 allergic disease Diseases 0.000 title abstract 2
230000007815 allergy Effects 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
244000036975 Ambrosia artemisiifolia Species 0.000 abstract 2
235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 abstract 2
239000013566 allergen Substances 0.000 abstract 2
235000003484 annual ragweed Nutrition 0.000 abstract 2
235000006263 bur ragweed Nutrition 0.000 abstract 2
235000003488 common ragweed Nutrition 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
235000009736 ragweed Nutrition 0.000 abstract 2
102000007079 Peptide Fragments Human genes 0.000 abstract 1
108010033276 Peptide Fragments Proteins 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
230000000172 allergic effect Effects 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000047 product Substances 0.000 abstract 1
239000009342 ragweed pollen Substances 0.000 abstract 1
230000004044 response Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/145—Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokola virus or vesicular stomatitis virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
General Physics & Mathematics (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Mycology (AREA)
Toxicology (AREA)
Botany (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)

AT09251252T 2008-08-15 2009-05-01 Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie ATE536880T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0814986A GB0814986D0 (en)	2008-08-15	2008-08-15	Peptide for il10 production
GB0815218A GB0815218D0 (en)	2008-08-20	2008-08-20	Ragweed peptides for vaccine

Publications (1)

Publication Number	Publication Date
ATE536880T1 true ATE536880T1 (de)	2011-12-15

Family

ID=41090318

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09251252T ATE536880T1 (de)	2008-08-15	2009-05-01	Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie

Country Status (18)

Country	Link
US (3)	US8491910B2 (de)
EP (3)	EP2444100A3 (de)
JP (1)	JP5788319B2 (de)
KR (1)	KR20110044787A (de)
CN (2)	CN102170897B (de)
AT (1)	ATE536880T1 (de)
AU (1)	AU2009281013B2 (de)
BR (1)	BRPI0917648A2 (de)
CA (1)	CA2734379A1 (de)
DK (1)	DK2153841T4 (de)
EA (1)	EA201170336A1 (de)
ES (1)	ES2378870T5 (de)
HR (1)	HRP20120206T4 (de)
MX (1)	MX2011001619A (de)
PL (1)	PL2153841T5 (de)
PT (1)	PT2153841E (de)
SI (1)	SI2153841T2 (de)
WO (1)	WO2010018378A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1958645A1 (de) *	2007-02-13	2008-08-20	Biomay AG	Peptide abgeleitet vom Hauptallergens von Traubenkraut (Ambrosia artemisiifolia) und deren Anwendung
EP2331124A1 (de)	2008-08-15	2011-06-15	Circassia Limited	T-zell-antigen-peptid aus einem allergen zur stimulierung der il-10-produktion
ES2378870T5 (es) *	2008-08-15	2016-02-03	Circassia Limited	Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía
JP5871819B2 (ja) *	2010-01-14	2016-03-01	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	プロリン残基の突然変異誘発により低減したアレルゲン性を有するイネ科のグループ５アレルゲンの変異体
FI20115374A0 (fi)	2011-04-18	2011-04-18	Teknologian Tutkimuskeskus Vtt Oy	Uudet hypoallergeenit
WO2013001362A2 (en) *	2011-06-27	2013-01-03	Anergis S.A.	Contiguous overlapping peptides for treatment of ragweed pollen allergy
CA2870399A1 (en) *	2012-04-16	2013-10-24	Alk-Abello A/S	Plant profilin polypeptides for use in non-specific allergy immunotherapy
JP6608282B2 (ja)	2012-10-30	2019-11-20	アラヴァックスピーティーワイリミテッド	新規免疫療法用分子およびその使用
WO2014138824A1 (en)	2013-03-15	2014-09-18	Sementis Limited	Immune modulation
RU2689552C2 (ru)	2013-09-25	2019-05-28	Аравакс Пти Лтд	Новая иммунотерапевтическая композиция и ее применения
WO2017179025A1 (en)	2016-04-15	2017-10-19	Alk-Abelló A/S	Epitope polypeptides of ragweed pollen allergens
EP3295956A1 (de)	2016-09-20	2018-03-21	Biomay Ag	Polypeptidkonstrukt mit fragmenten von allergenen
CN117362453B (zh) *	2023-12-08	2024-02-27	山东硕景生物科技有限公司	一种Derf1重组抗原、其制备方法及应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990011293A1 (en)	1989-03-17	1990-10-04	Immulogic Pharmaceutical Corporation	Allergenic proteins from ragweed and uses therefor
US5776761A (en) *	1989-03-17	1998-07-07	Immulogic Pharmaceutical Corporation	Nucleic acids encoding allergenic proteins from ragweed
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
US5399346A (en)	1989-06-14	1995-03-21	The United States Of America As Represented By The Department Of Health And Human Services	Gene therapy
WO1994001560A1 (en)	1991-07-12	1994-01-20	Immulogic Pharmaceutical Corporation	Allergenic proteins and peptides from japanese cedar pollen
EP0636180A1 (de)	1992-04-09	1995-02-01	Immulogic Pharmaceutical Corporation	T-zellen epitopen vom hauptallergen von ambrosia artemsiifolia
JPH07257419A (ja)	1994-03-24	1995-10-09	Kubota Corp	農作業車
US5820862A (en)	1994-04-14	1998-10-13	Immulogic Pharmaceutical Corporation	T cell epitopes of the major allergens from dermatophagoides (house dust mite)
IL115744A (en)	1994-10-27	2000-07-16	Akzo Nobel Nv	Peptides comprising a subsequence of human cartilage glycoprotein - 39
AU4146796A (en) *	1994-10-27	1996-05-23	Immulogic Pharmaceutical Corporation	T cell epitopes of the major allergens from ambrosia artemisiifolia
CA2317724A1 (en)	1998-01-09	1999-07-15	Circassia Limited	Methods and compositions for desensitisation
US6989146B2 (en)	2000-08-09	2006-01-24	The Regents Of The University Of California	Stress proteins and peptides and methods of use thereof
CA2469078A1 (en)	2001-12-05	2003-06-12	Circassia Limited	Immunotherapeutic methods and systems
AU2003228133A1 (en)	2002-04-22	2003-11-03	Umc Utrecht Holding B.V.	Reduction of unwanted immune reactions
GB0210741D0 (en)	2002-05-10	2002-06-19	Medical Res Council	Methods of therapy
GB0308988D0 (en)	2003-04-17	2003-05-28	Univ Singapore	Molecule
WO2006075253A2 (en)	2005-01-11	2006-07-20	Commissariat A L'energie Atomique	Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
SG160336A1 (en) *	2005-03-04	2010-04-29	Dynavax Tech Corp	Vaccines comprising oligonucleotides having immunostimulatory sequences (iss) wherein the iss are conjugated to antigens and stabilized by buffer conditions and further excipients
US20090130130A1 (en)	2005-06-10	2009-05-21	National University Of Singapore	Mutant allergen(s)
US20070092532A1 (en)	2005-10-25	2007-04-26	Board Of Trustees Operating Michigan State University	Arthritis vaccines and methods
CN100457180C (zh) *	2005-11-09	2009-02-04	浙江我武生物科技有限公司	用于治疗过敏性疾病的药物组合物及其制备方法
AU2006319216B2 (en)	2005-11-29	2012-09-13	Intrexon Actobiotics Nv	Induction of mucosal tolerance to antigens
AT503690A1 (de) *	2006-06-09	2007-12-15	Biomay Ag	Hypoallergene moleküle
EP1958645A1 (de)	2007-02-13	2008-08-20	Biomay AG	Peptide abgeleitet vom Hauptallergens von Traubenkraut (Ambrosia artemisiifolia) und deren Anwendung
US20110038881A1 (en)	2007-05-09	2011-02-17	Circassia Limited	Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en)	2007-06-01	2007-07-11	Circassia Ltd	Vaccine
EA023303B1 (ru)	2007-08-15	2016-05-31	Сиркейшиа Лимитед	Пептидная композиция для формирования толерантности к клещам домашней пыли и ее применение
ES2378870T5 (es) *	2008-08-15	2016-02-03	Circassia Limited	Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía

2009
- 2009-05-01 ES ES09251252.4T patent/ES2378870T5/es active Active
- 2009-05-01 EP EP11187162A patent/EP2444100A3/de not_active Withdrawn
- 2009-05-01 AT AT09251252T patent/ATE536880T1/de active
- 2009-05-01 EP EP11187164A patent/EP2433639A3/de not_active Withdrawn
- 2009-05-01 EP EP09251252.4A patent/EP2153841B2/de not_active Not-in-force
- 2009-05-01 PL PL09251252.4T patent/PL2153841T5/pl unknown
- 2009-05-01 DK DK09251252.4T patent/DK2153841T4/en active
- 2009-05-01 SI SI200930185T patent/SI2153841T2/sl unknown
- 2009-05-01 PT PT09251252T patent/PT2153841E/pt unknown
- 2009-08-14 AU AU2009281013A patent/AU2009281013B2/en not_active Ceased
- 2009-08-14 EA EA201170336A patent/EA201170336A1/ru unknown
- 2009-08-14 US US13/057,386 patent/US8491910B2/en not_active Expired - Fee Related
- 2009-08-14 KR KR1020117006048A patent/KR20110044787A/ko not_active Ceased
- 2009-08-14 MX MX2011001619A patent/MX2011001619A/es active IP Right Grant
- 2009-08-14 WO PCT/GB2009/001986 patent/WO2010018378A2/en not_active Ceased
- 2009-08-14 CN CN200980139316.6A patent/CN102170897B/zh not_active Expired - Fee Related
- 2009-08-14 CN CN201510016302.2A patent/CN104710512A/zh active Pending
- 2009-08-14 BR BRPI0917648A patent/BRPI0917648A2/pt not_active IP Right Cessation
- 2009-08-14 JP JP2011522549A patent/JP5788319B2/ja not_active Expired - Fee Related
- 2009-08-14 CA CA2734379A patent/CA2734379A1/en not_active Abandoned
2012
- 2012-03-02 HR HRP20120206TT patent/HRP20120206T4/hr unknown
2013
- 2013-06-14 US US13/917,756 patent/US9347937B2/en not_active Expired - Fee Related
2016
- 2016-04-28 US US15/140,724 patent/US20170014505A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN102170897B (zh)	2015-02-04
WO2010018378A8 (en)	2010-10-28
HRP20120206T1 (en)	2012-03-31
WO2010018378A2 (en)	2010-02-18
ES2378870T3 (es)	2012-04-18
AU2009281013B2 (en)	2015-01-29
US20170014505A1 (en)	2017-01-19
HRP20120206T4 (hr)	2016-02-12
CN104710512A (zh)	2015-06-17
SI2153841T2 (sl)	2016-02-29
JP5788319B2 (ja)	2015-09-30
EP2433639A3 (de)	2012-06-27
KR20110044787A (ko)	2011-04-29
US8491910B2 (en)	2013-07-23
CN102170897A (zh)	2011-08-31
SI2153841T1 (sl)	2012-04-30
DK2153841T3 (da)	2012-03-26
EP2444100A3 (de)	2012-07-25
EP2153841B1 (de)	2011-12-14
BRPI0917648A2 (pt)	2015-12-01
WO2010018378A3 (en)	2010-07-22
ES2378870T5 (es)	2016-02-03
PL2153841T3 (pl)	2012-05-31
US20120108524A1 (en)	2012-05-03
JP2012500193A (ja)	2012-01-05
EA201170336A1 (ru)	2011-10-31
AU2009281013A1 (en)	2010-02-18
MX2011001619A (es)	2011-03-25
US9347937B2 (en)	2016-05-24
EP2444100A2 (de)	2012-04-25
PT2153841E (pt)	2012-03-21
CA2734379A1 (en)	2010-02-18
US20130295123A1 (en)	2013-11-07
EP2153841A1 (de)	2010-02-17
EP2433639A2 (de)	2012-03-28
DK2153841T4 (en)	2016-02-15
PL2153841T5 (pl)	2016-09-30
EP2153841B2 (de)	2015-11-11

Publication	Publication Date	Title
HRP20120206T1 (en)	2012-03-31	Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
Fuchs et al.	1997	Natural latex, grass pollen, and weed pollen share IgE epitopes
CY1123304T1 (el)	2021-12-31	Αναστολη πεπτιδιων που προερχονται απο μεταγραφημα 1 τυπου trem (tlt-1) και χρησεις αυτωn
EA200501017A1 (ru)	2006-02-24	Астма и модуляторы аллергических воспалений
EA201200515A1 (ru)	2012-10-30	Полипептиды и их применение
CY1112655T1 (el)	2016-02-10	Γλυκοζυλιωμενη ιl-7, παρασκευη και χρησεις
WO2004078777A3 (en)	2006-02-16	Dipeptidyl-peptidase protected proteins
MX2021011726A (es)	2021-10-22	Escindasas modificadas, usos de las mismas y kits relacionados.
WO2008124646A3 (en)	2009-04-02	Use of amyloid proteins as vaccine scaffolds
NZ594268A (en)	2013-05-31	Grass peptides for vaccine
EA202190310A1 (ru)	2021-07-01	Белок для лечения воспалительных заболеваний
ATE463512T1 (de)	2010-04-15	Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
DE602006016133D1 (de)	2010-09-23	Verwendung von stefin a als gerüstprotein
MX2020012569A (es)	2021-02-18	Moleculas inmunoterapeuticas novedosas y sus usos.
EP3556857A3 (de)	2019-12-04	Cdc45l-peptide und impfstoffe damit
ATE552271T1 (de)	2012-04-15	Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
ATE400581T1 (de)	2008-07-15	Peptid-antioxidantien aus sojaproteinen
Davies et al.	2011	The dominant 55 kDa allergen of the subtropical Bahia grass (Paspalum notatum) pollen is a group 13 pollen allergen, Pas n 13
ES2550705T3 (es)	2015-11-11	Proteínas quiméricas hipoalergénicas pertenecientes a la familia de transferencia de lípidos de Parietaria judaica para usar en el tratamiento de alergias
WO2018200814A3 (en)	2018-12-06	Modified cyclic peptides and therapeutic use thereof
ATE473756T1 (de)	2010-07-15	Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
IL177698A0 (en)	2006-12-31	Fusion proeins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
WO2012073045A3 (en)	2012-09-27	Variants of trappins
WO2008070586A3 (en)	2008-10-16	Compositions and methods for treatment of protein misfolding and protein aggregation diseases
WO2016209959A2 (en)	2016-12-29	Peptide combinations and use thereof in treating cedar pollen allergy